Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Revolution Medicines Inc (RVMD)
Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,907,762
  • Shares Outstanding, K 164,690
  • Annual Sales, $ 35,380 K
  • Annual Income, $ -248,710 K
  • 60-Month Beta 1.54
  • Price/Sales 419.26
  • Price/Cash Flow N/A
  • Price/Book 2.66
Trade RVMD with:

Options Overview Details

View History
  • Implied Volatility 59.94% ( +1.14%)
  • Historical Volatility 32.18%
  • IV Percentile 34%
  • IV Rank 11.41%
  • IV High 176.22% on 10/20/23
  • IV Low 44.97% on 08/15/23
  • Put/Call Vol Ratio 1.67
  • Today's Volume 40
  • Volume Avg (30-Day) 137
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 6,507
  • Open Int (30-Day) 6,037

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.75
  • Number of Estimates 7
  • High Estimate -0.67
  • Low Estimate -0.85
  • Prior Year -0.72
  • Growth Rate Est. (year over year) -4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.80 +6.12%
on 02/05/24
32.28 -8.63%
on 02/27/24
+1.04 (+3.65%)
since 02/02/24
3-Month
23.38 +26.18%
on 12/05/23
32.28 -8.63%
on 02/27/24
+5.27 (+21.75%)
since 12/04/23
52-Week
15.44 +91.06%
on 10/23/23
35.60 -17.13%
on 10/17/23
+4.05 (+15.91%)
since 03/03/23

Most Recent Stories

More News
Why Revolution Medicines Stock Is Crashing Today

Investors were disappointed by Revolution Medicines' data, presented at ESMO.

RVMD : 29.50 (-1.01%)
Why Shares of Revolution Medicines Were Popping on Friday

The company released positive phase 1/1b trial data on two cancer therapies.

RVMD : 29.50 (-1.01%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, RVMD

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RETA : 172.36 (+0.02%)
EQRX : 2.34 (-2.09%)
RVMD : 29.50 (-1.01%)
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 14.29% and 68.36%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 29.50 (-1.01%)
IPSC : 4.10 (+3.54%)
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) delivered earnings and revenue surprises of -3.66% and 325.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

CRNX : 43.51 (-5.47%)
RVMD : 29.50 (-1.01%)
AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

AcelRx Pharmaceuticals (ACRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ACRX : 0.8600 (+7.50%)
RVMD : 29.50 (-1.01%)
Wall Street Analysts Think Revolution Medicines, Inc. (RVMD) Could Surge 27.24%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 27.2% in Revolution Medicines, Inc. (RVMD). While the effectiveness of this highly sought-after metric is questionable,...

RVMD : 29.50 (-1.01%)
Revolution Medicines, Inc. (RVMD) Expected to Beat Earnings Estimates: Should You Buy?

Revolution Medicines, Inc. (RVMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RVMD : 29.50 (-1.01%)
KPTI : 1.3100 (+10.55%)
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 25% and 127.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 29.50 (-1.01%)
RIGL : 1.4700 (-5.16%)
Are You Looking for a Top Momentum Pick? Why Revolution Medicines, Inc. (RVMD) is a Great Choice

Does Revolution Medicines, Inc. (RVMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

RVMD : 29.50 (-1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 31.36
2nd Resistance Point 30.79
1st Resistance Point 30.14
Last Price 29.50
1st Support Level 28.93
2nd Support Level 28.36
3rd Support Level 27.71

See More

52-Week High 35.60
Last Price 29.50
Fibonacci 61.8% 27.90
Fibonacci 50% 25.52
Fibonacci 38.2% 23.14
52-Week Low 15.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar